Cerebral Parenchymal Hemorrhage clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages 18-80
The primary objective of this multicenter randomized controlled study is to compare the safety and efficacy of minimally invasive hematoma evacuation with the Artemis Neuro Evacuation Device to best medical management for the treatment of intracerebral hemorrhage (ICH).
Our lead scientists for Cerebral Parenchymal Hemorrhage research studies include Geoffrey Colby.